Effects of dimethylphenylpiperazinium (DMPP) on the coronary circulation in the dog.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D004285:Dogs; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006426:Hemicholinium 3 / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D010830:Physostigmine / Q000494:pharmacology; D010879:Piperazines / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D014043:Tolazoline / Q000494:pharmacology
D006584:Hexamethonium Compounds; D010879:Piperazines; D006426:Hemicholinium 3; D001285:Atropine; D010830:Physostigmine; D011433:Propranolol; D014043:Tolazoline; D006145:Guanethidine